Suppr超能文献

大麻素法规的全州差异。

Statewide Variation in Cannabinoid Regulations.

作者信息

Stewart Katherine, Francis Vinald, Wightman Rachel S

机构信息

PGY3, Department of Emergency Medicine, Warren Alpert Medical School of Brown University.

Medical Illustration and Visual Design Specialist, Biomed Communications, Brown University.

出版信息

R I Med J (2013). 2023 Mar 1;106(2):31-33.

Abstract

As a growing number of states legalize the use of cannabinoids for medical and non-medical purposes, there continues to be large gaps in the understanding of appropriate dosing, impact on health, and the state's role in regulation of products. Here, we present a summary of 2022 cannabis regulations by state to evaluate for the presence of THC:CBD ratios, maximum THC concentration or content within products, specific caps for cannabis possession, and requirements for testing for cannabinoid content and/or contaminants such as pesticides and heavy metals. These results are presented in Map 1 and Table 1 and demonstrate substantial variation among product THC content, purchasing limits, and quality measurements across the country. Finally, we note there is currently no centralized data collection platform for this set of information between states as cannabis use evolves, creating poor transparency between consumers and state regulators.

摘要

随着越来越多的州将大麻素用于医疗和非医疗用途合法化,在对适当剂量、对健康的影响以及该州在产品监管中的作用的理解方面仍然存在很大差距。在此,我们总结了2022年各州的大麻法规,以评估四氢大麻酚(THC)与大麻二酚(CBD)的比例、产品中的最大THC浓度或含量、大麻持有量的具体上限,以及大麻素含量和/或农药和重金属等污染物检测的要求。这些结果列于图1和表1中,显示了全国各地产品THC含量、购买限制和质量测量方面的巨大差异。最后,我们注意到,随着大麻使用情况的演变,目前各州之间没有针对这套信息的集中数据收集平台,这导致消费者和州监管机构之间缺乏透明度。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验